SAN DIEGO--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, today entered a new era of life-science research by announcing the worldwide commercial availability of the SOLiD™ System, the company’s highly anticipated next-generation DNA sequencing platform. The SOLiD System is already enabling new ways of performing genetic analysis applications, which may set new standards for how scientists are able to approach complex challenges associated with understanding the biological basis for health and disease. The company made the announcement today at the 57th annual meeting of the American Society of Human Genetics.
